ClinicalTrials.gg
Sign In
Status unknownNCT03928977IMAGE AITUpdated Nov 19, 2019

Functional Imaging in the Acute Phase of Transient Ischemic Attacks

An interventional study of Functional Magnetic Resonance Imaging in Transient Ischemic Attack, sponsored by Centre Hospitalier Universitaire de Besancon. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-19.

Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Nov 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to find a radiological biomarker of Transient Ischemic Attacks (TIA) thanks to functional Magnetic Resonance Imaging (fMRI) done within the 24 hour after symptoms onset.

02

Conditions studied

  • Transient Ischemic Attack

Keywords

  • Transient Ischemic Attack
  • Stroke
  • functional Magnetic Resonance Imaging
03

In context

Ischemic Attack, Transient

298 studies on the registry are indexed under Ischemic Attack, Transient; 64 are open to participants now.

This study's planned enrollment of 70 is below the median of 206 across 166 interventional studies indexed under Ischemic Attack, Transient.

Browse Ischemic Attack, Transient studies →

Lead sponsor

Centre Hospitalier Universitaire de Besancon is the lead sponsor of 449 studies on the registry; 98 are open to participants now.

Browse Centre Hospitalier Universitaire de Besancon studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient admitted in for a transient neurologic deficit and suspicion of TIA of carotid circulation
  • Prescription for conventionnal MRI

Exclusion criteria

Exclusion Criteria:

  • Contraindication to MRI
  • Previous neurological disease (with lesions)
  • Severe psychiatric disease
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Other
    Confirmed TIA

    Confirmed TIA at 3 months with standardized neurological expertise

    Diagnostic Test: Functional Magnetic Resonance Imaging

  • Other
    Confirmed non-TIA

    Not-confirmed TIA at 3 months with standardized neurological expertise

    Diagnostic Test: Functional Magnetic Resonance Imaging

Interventions

  • Diagnostic testFunctional Magnetic Resonance Imaging

    fMRI sequences done with motor paradigm (right and left arm), followed by resting state acquisition

06

What researchers measure

Primary outcomes

  1. Blood-Oxygen-Level Dependent signal

    BOLD effect differences in motor cortex from pathological side versus healthy side measured by fMRI within the 24 hours after symptom onset, during a motor paradigm

    Time frame: 24 hours after symptoms onset

Secondary outcomes

  1. Resting state

    Bold effect differences in resting state networks from pathological side versus healthy side measured by fMRI within the 24 hours after symptom onset, during a motor paradigm

    Time frame: 24 hours after symptoms onset

07

Study locations

1 of 1 sites recruiting
  • CHU de Besançon
    Besançon, 25030, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03928977
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Responsible party
Sponsor
First posted
Apr 26, 2019
Start date
Oct 15, 2019
Primary completion
Feb 2021 (estimated)
Completion
Feb 2021 (estimated)
Last update
Nov 19, 2019

Study contacts

Louise BONNET, MD
Contact
l1bonnet@chu-besancon.fr
033381668984
Guillaume CHARBONNIER, MD
Contact
g1charbonnier@chu-besancon.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Ischemic Attack, Transient →

Other studies from this sponsor

Centre Hospitalier Universitaire de Besancon →

Start the discussion